ADORA2A and Alzheimer disease: Recently, Temido-Ferreira et al. demonstrated that the shift from LTD to LTP, considered a pathological form of synaptic plasticity that occurs in aged animals and in mouse models of Alzheimer’s disease, was corrected by an A2AR antagonist and a mGlu5R blockade [10].